STOCK TITAN

Avantor SEC Filings

AVTR NYSE

Welcome to our dedicated page for Avantor SEC filings (Ticker: AVTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to Avantor, Inc. (NYSE: AVTR) SEC filings, offering a view into the company’s financial reporting, governance updates and material events. Avantor is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries, and its regulatory filings document key aspects of this business.

Through Forms 10-K and 10-Q, readers can review Avantor’s audited annual and quarterly financial statements, along with management’s discussion of results, risk factors and segment information. Current reports on Form 8-K capture material developments such as quarterly earnings announcements, leadership and board changes, amendments to credit facilities, and other significant transactions. For example, recent 8-K filings describe the appointment of a new President and Chief Executive Officer, the creation of an Executive Vice President and Chief Operating Officer role, the election of new independent directors, and amendments to senior secured credit facilities and the termination of an accounts receivable securitization facility.

Avantor’s filings also explain the company’s use of non-GAAP financial measures, including Adjusted Operating Income, Adjusted EBITDA, adjusted net income, adjusted EPS, adjusted net leverage, free cash flow and free cash flow conversion, and provide reconciliations to comparable GAAP measures. Investors can use these disclosures to understand how management evaluates performance and capital structure.

On this page, Stock Titan pairs real-time EDGAR updates with AI-powered summaries that highlight the main points in each filing. Users can quickly identify items related to quarterly results, financing arrangements, governance changes and other topics, while still having access to the full original documents for detailed review.

Rhea-AI Summary

Form: Form 144 notice relating to Avantor, Inc. (Issuer stated: Avantor Inc).

Transaction: Proposed sale of 3,476 common shares through Merrill (address: 8890 Lyra Drive 5th Floor Columbus OH 43240) with an aggregate market value of $39,592.00. Approximate sale date is 08/05/2025 on the NYSE. Total shares outstanding reported: 681,738,675.

Acquisition: 1,033 shares were acquired via a Restricted Stock Grant Vest from Avantor Inc on 07/31/2025 with payment dated 07/31/2025. The filer reports Nothing to Report for securities sold in the past three months. Several filer identification/contact fields (e.g., CIK) are blank in the provided extract.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Form 4 filed for Avantor, Inc. (AVTR) reporting insider Steven W. Eck, SVP & Chief Accounting Officer. The report discloses a 07/31/2025 transaction coded F, described as shares withheld to cover tax withholding on vested RSUs.

  • Withheld shares: 1,385
  • Price shown: $13.44
  • Beneficially owned after transaction: 58,544 shares (Direct)
  • Filing signature/date: /s/ Scott Baker, Attorney-in-Fact, 08/04/2025

This is a routine tax-withholding event following RSU vesting; no open-market sale or derivative transactions are reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.48%
Tags
quarterly report
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.48%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.15%
Tags
current report
Rhea-AI Summary

Avantor, Inc. (AVTR) – SEC Form 4 filing

Company insider Corey Walker, President of Laboratory Solutions, reported a routine tax-related share withholding on 21 June 2025. The filing shows 2,730 common shares (transaction code F) were surrendered at an indicated price of $13.57 to satisfy statutory withholding obligations triggered by the vesting of restricted stock units (RSUs). After the transaction, Walker continues to hold 231,271 shares directly.

No derivative security activity, 10b5-1 plan disclosure, or additional insider transactions were reported. The small size of the disposition (≈1.2 % of Walker’s post-transaction holdings) and its tax-withholding nature make the event immaterial to the company’s capital structure and unlikely to influence the investment thesis for AVTR.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Avantor (AVTR)?

The current stock price of Avantor (AVTR) is $7.61 as of March 19, 2026.

What is the market cap of Avantor (AVTR)?

The market cap of Avantor (AVTR) is approximately 5.3B.

AVTR Rankings

AVTR Stock Data

5.25B
656.41M
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States
RADNOR

AVTR RSS Feed